Antithrombin reduces mesenteric venular leukocyte interactions and small intestine injury in endotoxemic rats

Shock

Volumn 15, Issue 3, 2001, Pages 220-225

  Nevière, Rémi ^a   Tournoys, Antoine ^c   Mordon, Serge ^c   Maréchal, Xavier ^c   Song, Fang Lu ^b   Jourdain, Mercé ^c   Fourrier, Francois ^c  

^a UNIV LILLE   (France)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Pôle Recherche ^*

Author keywords

Antithrombin; Coagulation; Endotoxin; Intravital microscopy; Leukocyte adhesion; Microvascular; Permeability; Small intestine

Indexed keywords

ANTITHROMBIN III; ENDOTOXIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BLOOD CLOTTING; CELL ADHESION; DRUG EFFECT; ENDOTOXEMIA; FIBRINOLYSIS; HUMAN; INTESTINE MUCOSA; LEUKOCYTE; MESENTERIC VEIN; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SMALL INTESTINE; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; ANTITHROMBIN III; BLOOD COAGULATION; CELL ADHESION; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; ENDOTOXINS; FIBRINOLYSIS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; LEUKOCYTES; MESENTERIC VEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VENULES;

EID: 0035293659     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115030-00010     Document Type: Article

References (34)

1. Bone RC: Inhibitors of complement and neutrophils: a critical evaluation of their role in the treatment of sepsis. Crit Care Med 20:891-898, 1992.
2. Simms HH: Polymorphonuclear leukocytes: their role as central cellular elements in shock pathogenesis. Shock 4:225-231, 1995.
3. Harris NR, Russel JM, Granger DN: Mediators of endotoxin-induced leukocyte adhesion in mesenteric post-capillary venules. Circ Shock 43:155-160, 1994.
4. Kurose I, Suematsu M, Miura S, Fukumura D, Sekizuka E, Nagata H, Oshio C, Tsuchiya M: Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery: attenuating effect of cetraxate. Toxicol Appl Pharmacol 120:37-44, 1993.
5. Walsh CJ, Sugerman HJ, Mullen PG, Carey PD, Leeper-Woodford SK, Jesmok GJ, Ellis EF, Fowler AA: Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. Arch Surg 127:138-144, 1992.
6. Thomas JR, Harlan JM, Rice CL, Winn RK: Role of leukocyte CD11/CD18 complex in endotoxic and septic shock in rabbits. J Appl Physiol 73:1510-1516, 1992.
7. Jaeschke H, Farhood A, Smith CW: Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 261:G1051-G1056, 1991.
8. Dickneite G: Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost 24:61-69, 1998.
9. Vervloet MG, Thijs LG, Hack CE: Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 24:33-44, 1998.
10. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882-888, 1993.
11. Balk R, Emerson T, Fourrier F, Kruse JA, Mammen EF, Schuster HP, Vinazzer H: Therapeutic use of antithrombin concentrate in sepsis. Semin Thromb Hemost 24:183-194, 1998.
12. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR, Fourrier F, Heinrichs H, Delvos U: Antithrombin III in patients with severe sepsis: a randomized, placebo-controlled, double-blind multicenter trial plus a metaanalysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 24:663-672, 1998.
13. Dickneite G, Paques EP: Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae-induced sepsis. Thromb Haemost 69:98-102, 1993.
14. Taylor FBJ, Emerson TE, Jordan R, Chang AK, Blick KE: Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 26:227-235, 1988.
15. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 270:L921-L930, 1996.
16. Okajima K, Uchiba M: The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost 24:27-32, 1998.
17. Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P: Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 96:2302-2310, 1997.
18. Woodman RC, Ostrovsky L, Teoh D, Payne D, Poon MC, Kubes P: Antithrombin and ischemia/reperfusion. Blood Coagul Fibrinolysis 9 (suppl 2):S7-S15, 1998.
19. Fourrier F, Jourdain M, Tournoys A, Gosset P, Mangalaboyi J, Chopin C: Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock. Shock 10:364-370, 1998.
20. Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M: Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock 10:90-96, 1998.
21. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP: Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 113:1246-1257, 1997.
22. Bone RC: Modulators of coagulation: a critical appraisal of their role in sepsis. Arch Intern Med 152:1381-1389, 1992.
23. Rosenberg RD, Aird WC: Vascular bed-specific hemostasis and hypercoagulable states. N Engl J Med 340:1555-1564, 1999.
24. Levi M, Ten Cate H, van der PT, van Deventer SJ: Pathogenesis of disseminated intravascular coagulation in sepsis. J Am Med Assoc 270:975-979, 1993.
25. Mayeux PR: Pathobiology of lipopolysaccharide. J Toxicol Environ Health 51:415-435, 1997.
26. McCuskey RS, Urbaschek R, Urbaschek B: The microcirculation during endotoxemia. Cardiovasc Res 32:752-763, 1996.
27. Zimmerman GA, McIntyre TM, Prescott SM: Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Investig 76:2235-2246, 1985.
28. Zimmerman GA, McIntyre TM, Prescott SM: Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. Ann NY Acad Sci 485:349-368, 1986.
29. Shankar R, de la Motte CA, Poptic EJ, DiCorleto PE: Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J Biol Chem 269:13936-13941, 1994.
30. Sugama Y, Tiruppathi C, Offakidevi K, Andersen TT, Fenton JW, Malik AB: Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol 119:935-944, 1992.
31. Gray E, Thomas S, Mistry Y, Poole S: Inhibition of tissue factor and cytokine release. Haemostasis 26 (suppl 1):92-95, 1996.
32. Wilharm E, Parry MA, Friebel R, Tschesche H, Matschiner G, Sommerhoff CP, Jenne DE: Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J Biol Chem 274:27331-27337, 1999.
33. Harada N, Okajama K, Kushimoto S, Isobe H, Tanaka K: Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 93:157-164, 1999.
34. Uchiba M, Okajima K: Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. Semin Thromb Hemost 23:583-590, 1997.